SCHEMBL4215930

SCHEMBL4215930

CC(C)C(=O)O[C@]1(C(=O)O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 13/20 0.62
▸ PGR P06401 8/20 0.62
▸ HIF1A Q16665 4/20 0.62
▸ NR1I2 O75469 3/20 0.62
▸ CNR1 P21554 2/20 0.62
▸ LMNA P02545 2/20 0.62
▸ ADORA3 P0DMS8 1/20 0.54
▸ OPRK1 P41145 1/20 0.54
▸ HSD17B10 Q99714 2/20 0.51
▸ ABCB11 O95342 2/20 0.51
▸ CYP3A4 P08684 2/20 0.51
▸ TNF P01375 1/20 0.51
▸ IL6 P05231 1/20 0.51
▸ SERPINA6 P08185 1/20 0.51
▸ NR3C2 P08235 1/20 0.51
▸ AR P10275 1/20 0.51
▸ GLUL P15104 1/20 0.51
▸ ADAM17 P78536 1/20 0.51
▸ GPBAR1 Q8TDU6 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11230636 0.90 NR3C1 (0.65) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL11586806 0.89 PGR (0.64) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL11586807 0.89 PGR (0.64) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL11234403 0.88 NR3C1 (0.69) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL11244253 0.86 NR3C1 (0.65) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL11791396 0.82 NR3C1 (0.58) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL11791454 0.82 NR3C1 (0.58) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL13699675 0.82 NR3C1 (0.61) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL11229603 0.82 NR3C1 (0.63) NR3C1PGRHIF1ANR1I2CNR1
SCHEMBL4222316 0.82 NR3C1 (0.63) NR3C1PGRHIF1ANR1I2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785425-B2 11β-hydroxyandrosta-4-ene-3-ones SUN PHARMA ADVANCED RESEARCH COMPANY LTD. 2014-07-22 — — US disclosed
US-20090054388-A1 NOVEL 11 BETA-HYDROXYANDROSTA-4-ENE-3-ONES SUN PHARMA ADVANCE RESEARCH COMPANY (IN) 2009-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054388-A1 NOVEL 11 BETA-HYDROXYANDROSTA-4-ENE-3-ONES HSD11B1, HSD3B1, HSD3B2 NR3C1 37/4885PGR 146/4885HIF1A 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback